0001708138-21-000096.txt : 20211210 0001708138-21-000096.hdr.sgml : 20211210 20211210173757 ACCESSION NUMBER: 0001708138-21-000096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211208 FILED AS OF DATE: 20211210 DATE AS OF CHANGE: 20211210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Landry Robert E CENTRAL INDEX KEY: 0001585160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 211486432 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-12-08 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001585160 Landry Robert E 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Finance CFO Common Stock 2021-12-08 4 A 0 3971 0.0 A 29957 D Common Stock 2021-12-09 4 M 0 4250 399.66 A 34207 D Common Stock 2021-12-09 4 F 0 3469 657.11 D 30738 D Common Stock 2021-12-10 4 S 0 2 656.46 D 30736 D Common Stock 2021-12-10 4 S 0 50 657.53 D 30686 D Common Stock 2021-12-10 4 S 0 11 658.52 D 30675 D Common Stock 2021-12-10 4 S 0 4 659.49 D 30671 D Common Stock 2021-12-10 4 S 0 25 661.48 D 30646 D Common Stock 2021-12-10 4 S 0 123 662.06 D 30523 D Common Stock 2021-12-10 4 S 0 19 663.41 D 30504 D Common Stock 2021-12-10 4 S 0 15 664.71 D 30489 D Common Stock 2021-12-10 4 S 0 18 665.44 D 30471 D Common Stock 2021-12-10 4 S 0 68 666.19 D 30403 D Common Stock 2021-12-10 4 S 0 7 667.8 D 30396 D Common Stock 2021-12-10 4 S 0 178 668.21 D 30218 D Common Stock 2021-12-10 4 S 0 130 669.48 D 30088 D Common Stock 2021-12-10 4 S 0 58 670.13 D 30030 D Common Stock 2021-12-10 4 S 0 14 671.42 D 30016 D Common Stock 2021-12-10 4 S 0 59 672.3 D 29957 D Common Stock 229 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 399.66 2021-12-09 4 M 0 4250 0.0 D 2024-12-16 Common Stock 4250 17000 D Non-Qualified Stock Option (right to buy) 644.54 2021-12-08 4 A 0 16958 0.0 A 2031-12-08 Common Stock 16958 16958 D Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 50 shares of Company stock on December 10, 2021 at prices ranging from $657.19 to $657.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 11 shares of Company stock on December 10, 2021 at prices ranging from $658.10 to $658.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 4 shares of Company stock on December 10, 2021 at prices ranging from $659.36 to $659.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 25 shares of Company stock on December 10, 2021 at prices ranging from $661.26 to $661.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 123 shares of Company stock on December 10, 2021 at prices ranging from $662.06 to $662.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 19 shares of Company stock on December 10, 2021 at prices ranging from $663.16 to $663.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 18 shares of Company stock on December 10, 2021 at prices ranging from $665.20 to $665.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 7 shares of Company stock on December 10, 2021 at prices ranging from $667.39 to $667.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 178 shares of Company stock on December 10, 2021 at prices ranging from $668.10 to $668.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 130 shares of Company stock on December 10, 2021 at prices ranging from $669.43 to $669.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 58 shares of Company stock on December 10, 2021 at prices ranging from $670.12 to $670.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. Represents volume-weighted average price of sales of 14 shares of Company stock on December 10, 2021 at prices ranging from $671.42 to $671.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Robert E. Landry 2021-12-10